KBC Group NV Buys 1,683,160 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

KBC Group NV raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 9,023.5% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,701,813 shares of the company's stock after purchasing an additional 1,683,160 shares during the quarter. KBC Group NV owned approximately 0.78% of Bath & Body Works worth $54,322,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of BBWI. First Community Trust NA acquired a new stake in shares of Bath & Body Works in the second quarter valued at approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt increased its stake in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company's stock valued at $38,000 after buying an additional 900 shares during the period. EntryPoint Capital LLC raised its position in shares of Bath & Body Works by 224.0% during the first quarter. EntryPoint Capital LLC now owns 1,471 shares of the company's stock worth $74,000 after acquiring an additional 1,017 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Bath & Body Works by 65.4% during the second quarter. GAMMA Investing LLC now owns 1,846 shares of the company's stock valued at $72,000 after acquiring an additional 730 shares during the period. Finally, Blue Trust Inc. boosted its holdings in Bath & Body Works by 23.4% in the second quarter. Blue Trust Inc. now owns 2,767 shares of the company's stock valued at $108,000 after acquiring an additional 524 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company's stock.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of the firm's stock in a transaction that occurred on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is owned by corporate insiders.

Bath & Body Works Price Performance

BBWI traded up $0.21 during trading on Friday, reaching $31.54. The company had a trading volume of 3,106,142 shares, compared to its average volume of 3,824,527. The company has a market cap of $6.91 billion, a P/E ratio of 7.55, a PEG ratio of 1.00 and a beta of 1.79. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The business's fifty day moving average price is $30.12 and its 200 day moving average price is $36.60.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.35 by $0.02. The business had revenue of $1.53 billion for the quarter, compared to analysts' expectations of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.54%. Bath & Body Works's dividend payout ratio is currently 19.37%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Citigroup dropped their price objective on Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating for the company in a report on Tuesday, August 20th. Wells Fargo & Company cut their price objective on shares of Bath & Body Works from $35.00 to $32.00 and set an "equal weight" rating on the stock in a report on Wednesday, November 6th. JPMorgan Chase & Co. lowered their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a "neutral" rating for the company in a report on Thursday, August 29th. BMO Capital Markets reiterated an "outperform" rating and set a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Finally, Evercore ISI reduced their price target on Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating on the stock in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $42.44.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.